Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Globus Medical Inc (NYSE:GMED)

Delayed Data
As of May 26
 -0.10 / -0.32%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Globus Medical, Inc. is a medical device company, which focuses on developing products that promote healing in patients with musculoskeletal disorders. The company also focuses on products to treat patients with spine disorders. Its products fall into two categories: Innovative Fusion and Disruptive Technologies. The Innovative Fusion products comprise fusion products to treat a wide variety of spinal disorders for the entire spine and can be used in a variety of surgical approaches. The Disruptive Technologies as those that represent a significant shift in the treatment of spinal disorders by allowing for novel surgical procedures, improvements to existing surgical procedures and the treatment of spinal disorders earlier in the continuum of care. Globus Medical was founded by David Paul, David M. Demski and David D. Davidar in March 2003 and is headquartered in Audubon, PA.

Contact Information

Globus Medical, Inc.
Valley Forge Business Center
Audubon Pennsylvania 19403
P:(610) 930-1800
Investor Relations:



Mutual fund holders51.38%
Other institutional46.03%
Individual stakeholders24.05%

Top Executives

David C. PaulChairman & Chief Executive Officer
Anthony L. WilliamsPresident
Daniel T. ScavillaCFO, Senior VP & Head-Investor Relations
David M. DemskiDirector & President-Emerging Technologies
Brett A. MurphyGroup President-Commercial Operations